Wuxi Zhongde Meilian Biotechnology Co., Ltd. was founded by overseas returnees in December 2006 with a registered capital of RMB 10 million. It is a biotech high-tech enterprise integrating R&D, production, sales and technical services.
As a key introduced project of Jiangsu Province and one of the first batch of high-tech enterprises under Wuxi's 530 Plan, Zhongde Meilian has grown rapidly and, in just six years, has become a leading enterprise in China's nucleic acid testing field. A number of DNA detection technologies independently developed by our company have obtained national invention patents, and multiple research projects have been included in the National Twelfth Five-Year Plan. The company has undertaken many national, provincial and municipal key projects, including the National 863 Program, the National Science and Technology Support Program, the Ministry of Public Security's key research program, and major Jiangsu provincial achievement transformation projects.
Among the world's only five manufacturers of STR DNA detection reagents, Zhongde Meilian is the only one that independently masters all core technologies and core raw materials. Our forensic DNA detection series products and supporting solutions feature fully independent intellectual property rights and leading core technical performance, fill domestic gaps, break international monopolies, and have been widely used by domestic public security, judicial, university and research institutions, winning broad recognition and praise from users. With the company's rapid development, beyond the forensic testing field, the company is actively exploring the civil market for nucleic acid testing and has successfully developed domestically leading children's genetic disease screening kits and canine DNA detection technology.
In 2013, on the basis of its existing forensic testing products, Zhongde Meilian will launch more advanced products and enter broader markets and fields such as healthcare, agriculture, food, environmental protection, and inspection and quarantine, further strengthening international cooperation, introducing cutting-edge foreign technologies and top-tier talent, and making every effort to build Zhongde Meilian into a leading brand in China's nucleic acid testing. The company has established a sales and R&D center in Shanghai and will soon jointly establish a clinical testing reagent R&D laboratory center with Zhejiang Women's Hospital in Hangzhou, ultimately forming a systematic nucleic acid testing company covering the entire biological chain.
At present, Zhongde Meilian has more than 3,000 square meters of R&D, production and office space and nearly 100 employees, including more than 30 PhDs and master's degree holders; over 85% hold a bachelor's degree or above, and the average age is about 28.
A brilliant career needs outstanding talent. Zhongde Meilian warmly welcomes professionals in research, marketing, management, production and technical services to join us in creating a great future!
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows